BMC Anesthesiology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2280102, encodeId=256d228010205, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：临床麻醉学 经验分享： 两个半月接收三个月见刊在BMC系列里算快的了吧对创新性要求不强审稿不算太水也没太严格Submission received Submission status Date Submission received 03 Mar 2025 Technical check Submission status Date Submission is under technical check 03 Mar 2025 Amendment requested 04 Mar 2025 Amendment received 04 Mar 2025 Submission passed technical check 10 Mar 2025 Editorial assignment Submission status Date Ready for editorial assignment 10 Mar 2025 With editor Submission status Date Editor assigned 10 Mar 2025 Peer review Submission status Date First reviewer(s) invited 24 Apr 2025 Reviewer(s) accepted 24 Apr 2025 Reviewer report(s) received 24 Apr 2025 Revision requested 28 Apr 2025 Revision received 05 May 2025 Submission passed technical check 08 May 2025 First reviewer(s) invited 09 May 2025 Reviewer(s) accepted 10 May 2025 Reviewer report(s) received 10 May 2025 Revision requested 12 May 2025 Revision received 17 May 2025 Submission passed technical check 20 May 2025 Submission accepted Submission status Date Submission accepted 21 May 2025 Publishing and rights Submission status Date Submission is in publishing and rights 27 May 2025 Production Submission status Date Publishing and rights complete 29 May 2025, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210827/3f96cfbc51d94516954ad67041b7684d/191c72c642f24136aa1144f5d40df49e.jpg, createdBy=fab55511324, createdName=阿克赛普蒂德, createdTime=Fri Sep 05 11:16:19 CST 2025, time=2025-09-05, status=1, ipAttribution=京都府), GetPortalCommentsPageByObjectIdResponse(id=2217603, encodeId=958f221e6036a, content=2024年投的第三篇，前两篇基本都是三个月左右接受，第三篇龟速。4.22投，5.10开始外审，官网显示5.17收到审稿人报告，但是一直还是peer review的状态。给编辑发了好几封邮件均石沉大海。有点无语！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Tue Jul 30 15:22:38 CST 2024, time=2024-07-30, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2231274, encodeId=cfd522312e4cc, content=别投，3周还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b7a9138890, createdName=ms7000000580164983, createdTime=Thu Oct 17 06:20:12 CST 2024, time=2024-10-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2229828, encodeId=19f32229828de, content=审稿速度:6.0 偏重的研究方向：临床麻醉 经验分享：审稿特别特别慢，小修一次，之后又等了三个多月了，到现在啥消息也没有，据说是找不到审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec371560063, createdName=caoyanting2, createdTime=Tue Oct 08 15:44:11 CST 2024, time=2024-10-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192762, encodeId=88f62192e6261, content= 投稿需要 provide a separate document detailing the trial protocol in the English language only? 这个怎么写，感觉要写好多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9bb51305814, createdName=inchina888999, createdTime=Tue Mar 12 14:43:07 CST 2024, time=2024-03-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2214457, encodeId=c06e221445ecc, content=2024中的第二篇，给各位同志分享一下时间线以供参考 Submission received 30 Apr 2024 Submission is under technical check 30 Apr 2024 Amendment requested 14 May 2024 Amendment received 14 May 2024 Submission passed technical check 25 May 2024 Ready for editorial assignment 25 May 2024 Editor assigned 25 May 2024 Submission under peer review 28 May 2024 Revision requested 28 Jun 2024 Revision received 02 Jul 2024 Submission accepted 11 Jul 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Thu Jul 11 14:29:56 CST 2024, time=2024-07-11, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2211917, encodeId=2982221191ecc, content=投了一篇meta Submission received 07 Mar 2024 Submission passed technical check 07 Mar 2024 Editor assigned 13 Mar 2024 Submission under peer review 13 Mar 2024 Revision received 27 May 2024 Submission accepted 27 Jun 2024 Submission is in publishing and rights 27 Jun 2024 优点：英国老牌杂志，不算水刊，有一定认可度，编辑也比较友好，审稿人也比较负责，提的意见还算中肯，对meta友好。 缺点：BMC出了名的比较墨迹，编辑回邮件有的时候间隔时间很长。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Thu Jun 27 11:47:20 CST 2024, time=2024-06-27, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2204336, encodeId=9178220433690, content=审稿周期长，半年多才一审回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1455249596, createdName=147dadaam95暂无昵称, createdTime=Mon May 13 00:17:14 CST 2024, time=2024-05-13, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2183976, encodeId=856821839e6c6, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床研究 经验分享：投稿到接收不到4个月，挺顺利，一审小修，二审后直接接收！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96494708137, createdName=1468631587, createdTime=Thu Jan 25 22:03:29 CST 2024, time=2024-01-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2169625, encodeId=2ebc2169625d4, content=审稿速度:6.0 经验分享：现在审稿很墨迹，非常墨迹，得写几次催稿信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/p4eiaaeyWK5jaz5mPZiclWDxjXuM9aLBsbvyksLkRSTu03YPasOw7rxzqWvqVv5dPaZtV9pviatTnSIibmyXqMLzog/0, createdBy=2d701415129, createdName=bonnie-yh, createdTime=Mon Nov 20 08:54:20 CST 2023, time=2023-11-20, status=1, ipAttribution=广东省)]

2025-09-05 阿克赛普蒂德来自京都府

审稿速度:3.0 | 投稿命中率:95.0
偏重的研究方向：临床麻醉学
经验分享：
两个半月接收三个月见刊在BMC系列里算快的了吧对创新性要求不强审稿不算太水也没太严格Submission received
Submission status Date
Submission received
03 Mar 2025
Technical check
Submission status Date
Submission is under technical check
03 Mar 2025
Amendment requested
04 Mar 2025
Amendment received
04 Mar 2025
Submission passed technical check
10 Mar 2025
Editorial assignment
Submission status Date
Ready for editorial assignment
10 Mar 2025
With editor
Submission status Date
Editor assigned
10 Mar 2025
Peer review
Submission status Date
First reviewer(s) invited
24 Apr 2025
Reviewer(s) accepted
24 Apr 2025
Reviewer report(s) received
24 Apr 2025
Revision requested
28 Apr 2025
Revision received
05 May 2025
Submission passed technical check
08 May 2025
First reviewer(s) invited
09 May 2025
Reviewer(s) accepted
10 May 2025
Reviewer report(s) received
10 May 2025
Revision requested
12 May 2025
Revision received
17 May 2025
Submission passed technical check
20 May 2025
Submission accepted
Submission status Date
Submission accepted
21 May 2025
Publishing and rights
Submission status Date
Submission is in publishing and rights
27 May 2025
Production
Submission status Date
Publishing and rights complete
29 May 2025

56 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2280102, encodeId=256d228010205, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：临床麻醉学 经验分享： 两个半月接收三个月见刊在BMC系列里算快的了吧对创新性要求不强审稿不算太水也没太严格Submission received Submission status Date Submission received 03 Mar 2025 Technical check Submission status Date Submission is under technical check 03 Mar 2025 Amendment requested 04 Mar 2025 Amendment received 04 Mar 2025 Submission passed technical check 10 Mar 2025 Editorial assignment Submission status Date Ready for editorial assignment 10 Mar 2025 With editor Submission status Date Editor assigned 10 Mar 2025 Peer review Submission status Date First reviewer(s) invited 24 Apr 2025 Reviewer(s) accepted 24 Apr 2025 Reviewer report(s) received 24 Apr 2025 Revision requested 28 Apr 2025 Revision received 05 May 2025 Submission passed technical check 08 May 2025 First reviewer(s) invited 09 May 2025 Reviewer(s) accepted 10 May 2025 Reviewer report(s) received 10 May 2025 Revision requested 12 May 2025 Revision received 17 May 2025 Submission passed technical check 20 May 2025 Submission accepted Submission status Date Submission accepted 21 May 2025 Publishing and rights Submission status Date Submission is in publishing and rights 27 May 2025 Production Submission status Date Publishing and rights complete 29 May 2025, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210827/3f96cfbc51d94516954ad67041b7684d/191c72c642f24136aa1144f5d40df49e.jpg, createdBy=fab55511324, createdName=阿克赛普蒂德, createdTime=Fri Sep 05 11:16:19 CST 2025, time=2025-09-05, status=1, ipAttribution=京都府), GetPortalCommentsPageByObjectIdResponse(id=2217603, encodeId=958f221e6036a, content=2024年投的第三篇，前两篇基本都是三个月左右接受，第三篇龟速。4.22投，5.10开始外审，官网显示5.17收到审稿人报告，但是一直还是peer review的状态。给编辑发了好几封邮件均石沉大海。有点无语！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Tue Jul 30 15:22:38 CST 2024, time=2024-07-30, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2231274, encodeId=cfd522312e4cc, content=别投，3周还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b7a9138890, createdName=ms7000000580164983, createdTime=Thu Oct 17 06:20:12 CST 2024, time=2024-10-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2229828, encodeId=19f32229828de, content=审稿速度:6.0 偏重的研究方向：临床麻醉 经验分享：审稿特别特别慢，小修一次，之后又等了三个多月了，到现在啥消息也没有，据说是找不到审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec371560063, createdName=caoyanting2, createdTime=Tue Oct 08 15:44:11 CST 2024, time=2024-10-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192762, encodeId=88f62192e6261, content= 投稿需要 provide a separate document detailing the trial protocol in the English language only? 这个怎么写，感觉要写好多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9bb51305814, createdName=inchina888999, createdTime=Tue Mar 12 14:43:07 CST 2024, time=2024-03-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2214457, encodeId=c06e221445ecc, content=2024中的第二篇，给各位同志分享一下时间线以供参考 Submission received 30 Apr 2024 Submission is under technical check 30 Apr 2024 Amendment requested 14 May 2024 Amendment received 14 May 2024 Submission passed technical check 25 May 2024 Ready for editorial assignment 25 May 2024 Editor assigned 25 May 2024 Submission under peer review 28 May 2024 Revision requested 28 Jun 2024 Revision received 02 Jul 2024 Submission accepted 11 Jul 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Thu Jul 11 14:29:56 CST 2024, time=2024-07-11, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2211917, encodeId=2982221191ecc, content=投了一篇meta Submission received 07 Mar 2024 Submission passed technical check 07 Mar 2024 Editor assigned 13 Mar 2024 Submission under peer review 13 Mar 2024 Revision received 27 May 2024 Submission accepted 27 Jun 2024 Submission is in publishing and rights 27 Jun 2024 优点：英国老牌杂志，不算水刊，有一定认可度，编辑也比较友好，审稿人也比较负责，提的意见还算中肯，对meta友好。 缺点：BMC出了名的比较墨迹，编辑回邮件有的时候间隔时间很长。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Thu Jun 27 11:47:20 CST 2024, time=2024-06-27, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2204336, encodeId=9178220433690, content=审稿周期长，半年多才一审回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1455249596, createdName=147dadaam95暂无昵称, createdTime=Mon May 13 00:17:14 CST 2024, time=2024-05-13, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2183976, encodeId=856821839e6c6, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床研究 经验分享：投稿到接收不到4个月，挺顺利，一审小修，二审后直接接收！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96494708137, createdName=1468631587, createdTime=Thu Jan 25 22:03:29 CST 2024, time=2024-01-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2169625, encodeId=2ebc2169625d4, content=审稿速度:6.0 经验分享：现在审稿很墨迹，非常墨迹，得写几次催稿信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/p4eiaaeyWK5jaz5mPZiclWDxjXuM9aLBsbvyksLkRSTu03YPasOw7rxzqWvqVv5dPaZtV9pviatTnSIibmyXqMLzog/0, createdBy=2d701415129, createdName=bonnie-yh, createdTime=Mon Nov 20 08:54:20 CST 2023, time=2023-11-20, status=1, ipAttribution=广东省)]

2024-07-30 ms6000000673439938 来自甘肃省

2024年投的第三篇，前两篇基本都是三个月左右接受，第三篇龟速。4.22投，5.10开始外审，官网显示5.17收到审稿人报告，但是一直还是peer review的状态。给编辑发了好几封邮件均石沉大海。有点无语！

158 5 举报

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2280102, encodeId=256d228010205, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：临床麻醉学 经验分享： 两个半月接收三个月见刊在BMC系列里算快的了吧对创新性要求不强审稿不算太水也没太严格Submission received Submission status Date Submission received 03 Mar 2025 Technical check Submission status Date Submission is under technical check 03 Mar 2025 Amendment requested 04 Mar 2025 Amendment received 04 Mar 2025 Submission passed technical check 10 Mar 2025 Editorial assignment Submission status Date Ready for editorial assignment 10 Mar 2025 With editor Submission status Date Editor assigned 10 Mar 2025 Peer review Submission status Date First reviewer(s) invited 24 Apr 2025 Reviewer(s) accepted 24 Apr 2025 Reviewer report(s) received 24 Apr 2025 Revision requested 28 Apr 2025 Revision received 05 May 2025 Submission passed technical check 08 May 2025 First reviewer(s) invited 09 May 2025 Reviewer(s) accepted 10 May 2025 Reviewer report(s) received 10 May 2025 Revision requested 12 May 2025 Revision received 17 May 2025 Submission passed technical check 20 May 2025 Submission accepted Submission status Date Submission accepted 21 May 2025 Publishing and rights Submission status Date Submission is in publishing and rights 27 May 2025 Production Submission status Date Publishing and rights complete 29 May 2025, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210827/3f96cfbc51d94516954ad67041b7684d/191c72c642f24136aa1144f5d40df49e.jpg, createdBy=fab55511324, createdName=阿克赛普蒂德, createdTime=Fri Sep 05 11:16:19 CST 2025, time=2025-09-05, status=1, ipAttribution=京都府), GetPortalCommentsPageByObjectIdResponse(id=2217603, encodeId=958f221e6036a, content=2024年投的第三篇，前两篇基本都是三个月左右接受，第三篇龟速。4.22投，5.10开始外审，官网显示5.17收到审稿人报告，但是一直还是peer review的状态。给编辑发了好几封邮件均石沉大海。有点无语！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Tue Jul 30 15:22:38 CST 2024, time=2024-07-30, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2231274, encodeId=cfd522312e4cc, content=别投，3周还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b7a9138890, createdName=ms7000000580164983, createdTime=Thu Oct 17 06:20:12 CST 2024, time=2024-10-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2229828, encodeId=19f32229828de, content=审稿速度:6.0 偏重的研究方向：临床麻醉 经验分享：审稿特别特别慢，小修一次，之后又等了三个多月了，到现在啥消息也没有，据说是找不到审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec371560063, createdName=caoyanting2, createdTime=Tue Oct 08 15:44:11 CST 2024, time=2024-10-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192762, encodeId=88f62192e6261, content= 投稿需要 provide a separate document detailing the trial protocol in the English language only? 这个怎么写，感觉要写好多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9bb51305814, createdName=inchina888999, createdTime=Tue Mar 12 14:43:07 CST 2024, time=2024-03-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2214457, encodeId=c06e221445ecc, content=2024中的第二篇，给各位同志分享一下时间线以供参考 Submission received 30 Apr 2024 Submission is under technical check 30 Apr 2024 Amendment requested 14 May 2024 Amendment received 14 May 2024 Submission passed technical check 25 May 2024 Ready for editorial assignment 25 May 2024 Editor assigned 25 May 2024 Submission under peer review 28 May 2024 Revision requested 28 Jun 2024 Revision received 02 Jul 2024 Submission accepted 11 Jul 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Thu Jul 11 14:29:56 CST 2024, time=2024-07-11, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2211917, encodeId=2982221191ecc, content=投了一篇meta Submission received 07 Mar 2024 Submission passed technical check 07 Mar 2024 Editor assigned 13 Mar 2024 Submission under peer review 13 Mar 2024 Revision received 27 May 2024 Submission accepted 27 Jun 2024 Submission is in publishing and rights 27 Jun 2024 优点：英国老牌杂志，不算水刊，有一定认可度，编辑也比较友好，审稿人也比较负责，提的意见还算中肯，对meta友好。 缺点：BMC出了名的比较墨迹，编辑回邮件有的时候间隔时间很长。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Thu Jun 27 11:47:20 CST 2024, time=2024-06-27, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2204336, encodeId=9178220433690, content=审稿周期长，半年多才一审回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1455249596, createdName=147dadaam95暂无昵称, createdTime=Mon May 13 00:17:14 CST 2024, time=2024-05-13, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2183976, encodeId=856821839e6c6, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床研究 经验分享：投稿到接收不到4个月，挺顺利，一审小修，二审后直接接收！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96494708137, createdName=1468631587, createdTime=Thu Jan 25 22:03:29 CST 2024, time=2024-01-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2169625, encodeId=2ebc2169625d4, content=审稿速度:6.0 经验分享：现在审稿很墨迹，非常墨迹，得写几次催稿信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/p4eiaaeyWK5jaz5mPZiclWDxjXuM9aLBsbvyksLkRSTu03YPasOw7rxzqWvqVv5dPaZtV9pviatTnSIibmyXqMLzog/0, createdBy=2d701415129, createdName=bonnie-yh, createdTime=Mon Nov 20 08:54:20 CST 2023, time=2023-11-20, status=1, ipAttribution=广东省)]

2024-10-17 ms7000000580164983 来自山东省

别投，3周还是with editor

108 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2280102, encodeId=256d228010205, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：临床麻醉学 经验分享： 两个半月接收三个月见刊在BMC系列里算快的了吧对创新性要求不强审稿不算太水也没太严格Submission received Submission status Date Submission received 03 Mar 2025 Technical check Submission status Date Submission is under technical check 03 Mar 2025 Amendment requested 04 Mar 2025 Amendment received 04 Mar 2025 Submission passed technical check 10 Mar 2025 Editorial assignment Submission status Date Ready for editorial assignment 10 Mar 2025 With editor Submission status Date Editor assigned 10 Mar 2025 Peer review Submission status Date First reviewer(s) invited 24 Apr 2025 Reviewer(s) accepted 24 Apr 2025 Reviewer report(s) received 24 Apr 2025 Revision requested 28 Apr 2025 Revision received 05 May 2025 Submission passed technical check 08 May 2025 First reviewer(s) invited 09 May 2025 Reviewer(s) accepted 10 May 2025 Reviewer report(s) received 10 May 2025 Revision requested 12 May 2025 Revision received 17 May 2025 Submission passed technical check 20 May 2025 Submission accepted Submission status Date Submission accepted 21 May 2025 Publishing and rights Submission status Date Submission is in publishing and rights 27 May 2025 Production Submission status Date Publishing and rights complete 29 May 2025, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210827/3f96cfbc51d94516954ad67041b7684d/191c72c642f24136aa1144f5d40df49e.jpg, createdBy=fab55511324, createdName=阿克赛普蒂德, createdTime=Fri Sep 05 11:16:19 CST 2025, time=2025-09-05, status=1, ipAttribution=京都府), GetPortalCommentsPageByObjectIdResponse(id=2217603, encodeId=958f221e6036a, content=2024年投的第三篇，前两篇基本都是三个月左右接受，第三篇龟速。4.22投，5.10开始外审，官网显示5.17收到审稿人报告，但是一直还是peer review的状态。给编辑发了好几封邮件均石沉大海。有点无语！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Tue Jul 30 15:22:38 CST 2024, time=2024-07-30, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2231274, encodeId=cfd522312e4cc, content=别投，3周还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b7a9138890, createdName=ms7000000580164983, createdTime=Thu Oct 17 06:20:12 CST 2024, time=2024-10-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2229828, encodeId=19f32229828de, content=审稿速度:6.0 偏重的研究方向：临床麻醉 经验分享：审稿特别特别慢，小修一次，之后又等了三个多月了，到现在啥消息也没有，据说是找不到审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec371560063, createdName=caoyanting2, createdTime=Tue Oct 08 15:44:11 CST 2024, time=2024-10-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192762, encodeId=88f62192e6261, content= 投稿需要 provide a separate document detailing the trial protocol in the English language only? 这个怎么写，感觉要写好多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9bb51305814, createdName=inchina888999, createdTime=Tue Mar 12 14:43:07 CST 2024, time=2024-03-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2214457, encodeId=c06e221445ecc, content=2024中的第二篇，给各位同志分享一下时间线以供参考 Submission received 30 Apr 2024 Submission is under technical check 30 Apr 2024 Amendment requested 14 May 2024 Amendment received 14 May 2024 Submission passed technical check 25 May 2024 Ready for editorial assignment 25 May 2024 Editor assigned 25 May 2024 Submission under peer review 28 May 2024 Revision requested 28 Jun 2024 Revision received 02 Jul 2024 Submission accepted 11 Jul 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Thu Jul 11 14:29:56 CST 2024, time=2024-07-11, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2211917, encodeId=2982221191ecc, content=投了一篇meta Submission received 07 Mar 2024 Submission passed technical check 07 Mar 2024 Editor assigned 13 Mar 2024 Submission under peer review 13 Mar 2024 Revision received 27 May 2024 Submission accepted 27 Jun 2024 Submission is in publishing and rights 27 Jun 2024 优点：英国老牌杂志，不算水刊，有一定认可度，编辑也比较友好，审稿人也比较负责，提的意见还算中肯，对meta友好。 缺点：BMC出了名的比较墨迹，编辑回邮件有的时候间隔时间很长。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Thu Jun 27 11:47:20 CST 2024, time=2024-06-27, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2204336, encodeId=9178220433690, content=审稿周期长，半年多才一审回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1455249596, createdName=147dadaam95暂无昵称, createdTime=Mon May 13 00:17:14 CST 2024, time=2024-05-13, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2183976, encodeId=856821839e6c6, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床研究 经验分享：投稿到接收不到4个月，挺顺利，一审小修，二审后直接接收！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96494708137, createdName=1468631587, createdTime=Thu Jan 25 22:03:29 CST 2024, time=2024-01-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2169625, encodeId=2ebc2169625d4, content=审稿速度:6.0 经验分享：现在审稿很墨迹，非常墨迹，得写几次催稿信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/p4eiaaeyWK5jaz5mPZiclWDxjXuM9aLBsbvyksLkRSTu03YPasOw7rxzqWvqVv5dPaZtV9pviatTnSIibmyXqMLzog/0, createdBy=2d701415129, createdName=bonnie-yh, createdTime=Mon Nov 20 08:54:20 CST 2023, time=2023-11-20, status=1, ipAttribution=广东省)]

2024-10-08 caoyanting2 来自北京

审稿速度:6.0
偏重的研究方向：临床麻醉
经验分享：审稿特别特别慢，小修一次，之后又等了三个多月了，到现在啥消息也没有，据说是找不到审稿人。

106 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2280102, encodeId=256d228010205, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：临床麻醉学 经验分享： 两个半月接收三个月见刊在BMC系列里算快的了吧对创新性要求不强审稿不算太水也没太严格Submission received Submission status Date Submission received 03 Mar 2025 Technical check Submission status Date Submission is under technical check 03 Mar 2025 Amendment requested 04 Mar 2025 Amendment received 04 Mar 2025 Submission passed technical check 10 Mar 2025 Editorial assignment Submission status Date Ready for editorial assignment 10 Mar 2025 With editor Submission status Date Editor assigned 10 Mar 2025 Peer review Submission status Date First reviewer(s) invited 24 Apr 2025 Reviewer(s) accepted 24 Apr 2025 Reviewer report(s) received 24 Apr 2025 Revision requested 28 Apr 2025 Revision received 05 May 2025 Submission passed technical check 08 May 2025 First reviewer(s) invited 09 May 2025 Reviewer(s) accepted 10 May 2025 Reviewer report(s) received 10 May 2025 Revision requested 12 May 2025 Revision received 17 May 2025 Submission passed technical check 20 May 2025 Submission accepted Submission status Date Submission accepted 21 May 2025 Publishing and rights Submission status Date Submission is in publishing and rights 27 May 2025 Production Submission status Date Publishing and rights complete 29 May 2025, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210827/3f96cfbc51d94516954ad67041b7684d/191c72c642f24136aa1144f5d40df49e.jpg, createdBy=fab55511324, createdName=阿克赛普蒂德, createdTime=Fri Sep 05 11:16:19 CST 2025, time=2025-09-05, status=1, ipAttribution=京都府), GetPortalCommentsPageByObjectIdResponse(id=2217603, encodeId=958f221e6036a, content=2024年投的第三篇，前两篇基本都是三个月左右接受，第三篇龟速。4.22投，5.10开始外审，官网显示5.17收到审稿人报告，但是一直还是peer review的状态。给编辑发了好几封邮件均石沉大海。有点无语！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Tue Jul 30 15:22:38 CST 2024, time=2024-07-30, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2231274, encodeId=cfd522312e4cc, content=别投，3周还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b7a9138890, createdName=ms7000000580164983, createdTime=Thu Oct 17 06:20:12 CST 2024, time=2024-10-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2229828, encodeId=19f32229828de, content=审稿速度:6.0 偏重的研究方向：临床麻醉 经验分享：审稿特别特别慢，小修一次，之后又等了三个多月了，到现在啥消息也没有，据说是找不到审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec371560063, createdName=caoyanting2, createdTime=Tue Oct 08 15:44:11 CST 2024, time=2024-10-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192762, encodeId=88f62192e6261, content= 投稿需要 provide a separate document detailing the trial protocol in the English language only? 这个怎么写，感觉要写好多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9bb51305814, createdName=inchina888999, createdTime=Tue Mar 12 14:43:07 CST 2024, time=2024-03-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2214457, encodeId=c06e221445ecc, content=2024中的第二篇，给各位同志分享一下时间线以供参考 Submission received 30 Apr 2024 Submission is under technical check 30 Apr 2024 Amendment requested 14 May 2024 Amendment received 14 May 2024 Submission passed technical check 25 May 2024 Ready for editorial assignment 25 May 2024 Editor assigned 25 May 2024 Submission under peer review 28 May 2024 Revision requested 28 Jun 2024 Revision received 02 Jul 2024 Submission accepted 11 Jul 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Thu Jul 11 14:29:56 CST 2024, time=2024-07-11, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2211917, encodeId=2982221191ecc, content=投了一篇meta Submission received 07 Mar 2024 Submission passed technical check 07 Mar 2024 Editor assigned 13 Mar 2024 Submission under peer review 13 Mar 2024 Revision received 27 May 2024 Submission accepted 27 Jun 2024 Submission is in publishing and rights 27 Jun 2024 优点：英国老牌杂志，不算水刊，有一定认可度，编辑也比较友好，审稿人也比较负责，提的意见还算中肯，对meta友好。 缺点：BMC出了名的比较墨迹，编辑回邮件有的时候间隔时间很长。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Thu Jun 27 11:47:20 CST 2024, time=2024-06-27, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2204336, encodeId=9178220433690, content=审稿周期长，半年多才一审回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1455249596, createdName=147dadaam95暂无昵称, createdTime=Mon May 13 00:17:14 CST 2024, time=2024-05-13, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2183976, encodeId=856821839e6c6, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床研究 经验分享：投稿到接收不到4个月，挺顺利，一审小修，二审后直接接收！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96494708137, createdName=1468631587, createdTime=Thu Jan 25 22:03:29 CST 2024, time=2024-01-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2169625, encodeId=2ebc2169625d4, content=审稿速度:6.0 经验分享：现在审稿很墨迹，非常墨迹，得写几次催稿信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/p4eiaaeyWK5jaz5mPZiclWDxjXuM9aLBsbvyksLkRSTu03YPasOw7rxzqWvqVv5dPaZtV9pviatTnSIibmyXqMLzog/0, createdBy=2d701415129, createdName=bonnie-yh, createdTime=Mon Nov 20 08:54:20 CST 2023, time=2023-11-20, status=1, ipAttribution=广东省)]

2024-03-12 inchina888999 来自浙江省

投稿需要 provide a separate document detailing the trial protocol in the English language only? 这个怎么写，感觉要写好多

195 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2280102, encodeId=256d228010205, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：临床麻醉学 经验分享： 两个半月接收三个月见刊在BMC系列里算快的了吧对创新性要求不强审稿不算太水也没太严格Submission received Submission status Date Submission received 03 Mar 2025 Technical check Submission status Date Submission is under technical check 03 Mar 2025 Amendment requested 04 Mar 2025 Amendment received 04 Mar 2025 Submission passed technical check 10 Mar 2025 Editorial assignment Submission status Date Ready for editorial assignment 10 Mar 2025 With editor Submission status Date Editor assigned 10 Mar 2025 Peer review Submission status Date First reviewer(s) invited 24 Apr 2025 Reviewer(s) accepted 24 Apr 2025 Reviewer report(s) received 24 Apr 2025 Revision requested 28 Apr 2025 Revision received 05 May 2025 Submission passed technical check 08 May 2025 First reviewer(s) invited 09 May 2025 Reviewer(s) accepted 10 May 2025 Reviewer report(s) received 10 May 2025 Revision requested 12 May 2025 Revision received 17 May 2025 Submission passed technical check 20 May 2025 Submission accepted Submission status Date Submission accepted 21 May 2025 Publishing and rights Submission status Date Submission is in publishing and rights 27 May 2025 Production Submission status Date Publishing and rights complete 29 May 2025, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210827/3f96cfbc51d94516954ad67041b7684d/191c72c642f24136aa1144f5d40df49e.jpg, createdBy=fab55511324, createdName=阿克赛普蒂德, createdTime=Fri Sep 05 11:16:19 CST 2025, time=2025-09-05, status=1, ipAttribution=京都府), GetPortalCommentsPageByObjectIdResponse(id=2217603, encodeId=958f221e6036a, content=2024年投的第三篇，前两篇基本都是三个月左右接受，第三篇龟速。4.22投，5.10开始外审，官网显示5.17收到审稿人报告，但是一直还是peer review的状态。给编辑发了好几封邮件均石沉大海。有点无语！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Tue Jul 30 15:22:38 CST 2024, time=2024-07-30, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2231274, encodeId=cfd522312e4cc, content=别投，3周还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b7a9138890, createdName=ms7000000580164983, createdTime=Thu Oct 17 06:20:12 CST 2024, time=2024-10-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2229828, encodeId=19f32229828de, content=审稿速度:6.0 偏重的研究方向：临床麻醉 经验分享：审稿特别特别慢，小修一次，之后又等了三个多月了，到现在啥消息也没有，据说是找不到审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec371560063, createdName=caoyanting2, createdTime=Tue Oct 08 15:44:11 CST 2024, time=2024-10-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192762, encodeId=88f62192e6261, content= 投稿需要 provide a separate document detailing the trial protocol in the English language only? 这个怎么写，感觉要写好多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9bb51305814, createdName=inchina888999, createdTime=Tue Mar 12 14:43:07 CST 2024, time=2024-03-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2214457, encodeId=c06e221445ecc, content=2024中的第二篇，给各位同志分享一下时间线以供参考 Submission received 30 Apr 2024 Submission is under technical check 30 Apr 2024 Amendment requested 14 May 2024 Amendment received 14 May 2024 Submission passed technical check 25 May 2024 Ready for editorial assignment 25 May 2024 Editor assigned 25 May 2024 Submission under peer review 28 May 2024 Revision requested 28 Jun 2024 Revision received 02 Jul 2024 Submission accepted 11 Jul 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Thu Jul 11 14:29:56 CST 2024, time=2024-07-11, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2211917, encodeId=2982221191ecc, content=投了一篇meta Submission received 07 Mar 2024 Submission passed technical check 07 Mar 2024 Editor assigned 13 Mar 2024 Submission under peer review 13 Mar 2024 Revision received 27 May 2024 Submission accepted 27 Jun 2024 Submission is in publishing and rights 27 Jun 2024 优点：英国老牌杂志，不算水刊，有一定认可度，编辑也比较友好，审稿人也比较负责，提的意见还算中肯，对meta友好。 缺点：BMC出了名的比较墨迹，编辑回邮件有的时候间隔时间很长。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Thu Jun 27 11:47:20 CST 2024, time=2024-06-27, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2204336, encodeId=9178220433690, content=审稿周期长，半年多才一审回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1455249596, createdName=147dadaam95暂无昵称, createdTime=Mon May 13 00:17:14 CST 2024, time=2024-05-13, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2183976, encodeId=856821839e6c6, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床研究 经验分享：投稿到接收不到4个月，挺顺利，一审小修，二审后直接接收！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96494708137, createdName=1468631587, createdTime=Thu Jan 25 22:03:29 CST 2024, time=2024-01-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2169625, encodeId=2ebc2169625d4, content=审稿速度:6.0 经验分享：现在审稿很墨迹，非常墨迹，得写几次催稿信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/p4eiaaeyWK5jaz5mPZiclWDxjXuM9aLBsbvyksLkRSTu03YPasOw7rxzqWvqVv5dPaZtV9pviatTnSIibmyXqMLzog/0, createdBy=2d701415129, createdName=bonnie-yh, createdTime=Mon Nov 20 08:54:20 CST 2023, time=2023-11-20, status=1, ipAttribution=广东省)]

2024-07-11 ms6000000673439938 来自甘肃省

2024中的第二篇，给各位同志分享一下时间线以供参考
Submission received 30 Apr 2024
Submission is under technical check 30 Apr 2024
Amendment requested 14 May 2024
Amendment received 14 May 2024
Submission passed technical check 25 May 2024
Ready for editorial assignment 25 May 2024
Editor assigned 25 May 2024
Submission under peer review 28 May 2024
Revision requested 28 Jun 2024
Revision received 02 Jul 2024
Submission accepted 11 Jul 2024

153 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2280102, encodeId=256d228010205, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：临床麻醉学 经验分享： 两个半月接收三个月见刊在BMC系列里算快的了吧对创新性要求不强审稿不算太水也没太严格Submission received Submission status Date Submission received 03 Mar 2025 Technical check Submission status Date Submission is under technical check 03 Mar 2025 Amendment requested 04 Mar 2025 Amendment received 04 Mar 2025 Submission passed technical check 10 Mar 2025 Editorial assignment Submission status Date Ready for editorial assignment 10 Mar 2025 With editor Submission status Date Editor assigned 10 Mar 2025 Peer review Submission status Date First reviewer(s) invited 24 Apr 2025 Reviewer(s) accepted 24 Apr 2025 Reviewer report(s) received 24 Apr 2025 Revision requested 28 Apr 2025 Revision received 05 May 2025 Submission passed technical check 08 May 2025 First reviewer(s) invited 09 May 2025 Reviewer(s) accepted 10 May 2025 Reviewer report(s) received 10 May 2025 Revision requested 12 May 2025 Revision received 17 May 2025 Submission passed technical check 20 May 2025 Submission accepted Submission status Date Submission accepted 21 May 2025 Publishing and rights Submission status Date Submission is in publishing and rights 27 May 2025 Production Submission status Date Publishing and rights complete 29 May 2025, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210827/3f96cfbc51d94516954ad67041b7684d/191c72c642f24136aa1144f5d40df49e.jpg, createdBy=fab55511324, createdName=阿克赛普蒂德, createdTime=Fri Sep 05 11:16:19 CST 2025, time=2025-09-05, status=1, ipAttribution=京都府), GetPortalCommentsPageByObjectIdResponse(id=2217603, encodeId=958f221e6036a, content=2024年投的第三篇，前两篇基本都是三个月左右接受，第三篇龟速。4.22投，5.10开始外审，官网显示5.17收到审稿人报告，但是一直还是peer review的状态。给编辑发了好几封邮件均石沉大海。有点无语！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Tue Jul 30 15:22:38 CST 2024, time=2024-07-30, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2231274, encodeId=cfd522312e4cc, content=别投，3周还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b7a9138890, createdName=ms7000000580164983, createdTime=Thu Oct 17 06:20:12 CST 2024, time=2024-10-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2229828, encodeId=19f32229828de, content=审稿速度:6.0 偏重的研究方向：临床麻醉 经验分享：审稿特别特别慢，小修一次，之后又等了三个多月了，到现在啥消息也没有，据说是找不到审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec371560063, createdName=caoyanting2, createdTime=Tue Oct 08 15:44:11 CST 2024, time=2024-10-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192762, encodeId=88f62192e6261, content= 投稿需要 provide a separate document detailing the trial protocol in the English language only? 这个怎么写，感觉要写好多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9bb51305814, createdName=inchina888999, createdTime=Tue Mar 12 14:43:07 CST 2024, time=2024-03-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2214457, encodeId=c06e221445ecc, content=2024中的第二篇，给各位同志分享一下时间线以供参考 Submission received 30 Apr 2024 Submission is under technical check 30 Apr 2024 Amendment requested 14 May 2024 Amendment received 14 May 2024 Submission passed technical check 25 May 2024 Ready for editorial assignment 25 May 2024 Editor assigned 25 May 2024 Submission under peer review 28 May 2024 Revision requested 28 Jun 2024 Revision received 02 Jul 2024 Submission accepted 11 Jul 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Thu Jul 11 14:29:56 CST 2024, time=2024-07-11, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2211917, encodeId=2982221191ecc, content=投了一篇meta Submission received 07 Mar 2024 Submission passed technical check 07 Mar 2024 Editor assigned 13 Mar 2024 Submission under peer review 13 Mar 2024 Revision received 27 May 2024 Submission accepted 27 Jun 2024 Submission is in publishing and rights 27 Jun 2024 优点：英国老牌杂志，不算水刊，有一定认可度，编辑也比较友好，审稿人也比较负责，提的意见还算中肯，对meta友好。 缺点：BMC出了名的比较墨迹，编辑回邮件有的时候间隔时间很长。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Thu Jun 27 11:47:20 CST 2024, time=2024-06-27, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2204336, encodeId=9178220433690, content=审稿周期长，半年多才一审回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1455249596, createdName=147dadaam95暂无昵称, createdTime=Mon May 13 00:17:14 CST 2024, time=2024-05-13, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2183976, encodeId=856821839e6c6, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床研究 经验分享：投稿到接收不到4个月，挺顺利，一审小修，二审后直接接收！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96494708137, createdName=1468631587, createdTime=Thu Jan 25 22:03:29 CST 2024, time=2024-01-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2169625, encodeId=2ebc2169625d4, content=审稿速度:6.0 经验分享：现在审稿很墨迹，非常墨迹，得写几次催稿信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/p4eiaaeyWK5jaz5mPZiclWDxjXuM9aLBsbvyksLkRSTu03YPasOw7rxzqWvqVv5dPaZtV9pviatTnSIibmyXqMLzog/0, createdBy=2d701415129, createdName=bonnie-yh, createdTime=Mon Nov 20 08:54:20 CST 2023, time=2023-11-20, status=1, ipAttribution=广东省)]

2024-06-27 ms6000000673439938 来自甘肃省

投了一篇meta
Submission received 07 Mar 2024
Submission passed technical check 07 Mar 2024
Editor assigned 13 Mar 2024
Submission under peer review 13 Mar 2024
Revision received 27 May 2024
Submission accepted 27 Jun 2024
Submission is in publishing and rights 27 Jun 2024
优点：英国老牌杂志，不算水刊，有一定认可度，编辑也比较友好，审稿人也比较负责，提的意见还算中肯，对meta友好。
缺点：BMC出了名的比较墨迹，编辑回邮件有的时候间隔时间很长。

153 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2280102, encodeId=256d228010205, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：临床麻醉学 经验分享： 两个半月接收三个月见刊在BMC系列里算快的了吧对创新性要求不强审稿不算太水也没太严格Submission received Submission status Date Submission received 03 Mar 2025 Technical check Submission status Date Submission is under technical check 03 Mar 2025 Amendment requested 04 Mar 2025 Amendment received 04 Mar 2025 Submission passed technical check 10 Mar 2025 Editorial assignment Submission status Date Ready for editorial assignment 10 Mar 2025 With editor Submission status Date Editor assigned 10 Mar 2025 Peer review Submission status Date First reviewer(s) invited 24 Apr 2025 Reviewer(s) accepted 24 Apr 2025 Reviewer report(s) received 24 Apr 2025 Revision requested 28 Apr 2025 Revision received 05 May 2025 Submission passed technical check 08 May 2025 First reviewer(s) invited 09 May 2025 Reviewer(s) accepted 10 May 2025 Reviewer report(s) received 10 May 2025 Revision requested 12 May 2025 Revision received 17 May 2025 Submission passed technical check 20 May 2025 Submission accepted Submission status Date Submission accepted 21 May 2025 Publishing and rights Submission status Date Submission is in publishing and rights 27 May 2025 Production Submission status Date Publishing and rights complete 29 May 2025, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210827/3f96cfbc51d94516954ad67041b7684d/191c72c642f24136aa1144f5d40df49e.jpg, createdBy=fab55511324, createdName=阿克赛普蒂德, createdTime=Fri Sep 05 11:16:19 CST 2025, time=2025-09-05, status=1, ipAttribution=京都府), GetPortalCommentsPageByObjectIdResponse(id=2217603, encodeId=958f221e6036a, content=2024年投的第三篇，前两篇基本都是三个月左右接受，第三篇龟速。4.22投，5.10开始外审，官网显示5.17收到审稿人报告，但是一直还是peer review的状态。给编辑发了好几封邮件均石沉大海。有点无语！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Tue Jul 30 15:22:38 CST 2024, time=2024-07-30, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2231274, encodeId=cfd522312e4cc, content=别投，3周还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b7a9138890, createdName=ms7000000580164983, createdTime=Thu Oct 17 06:20:12 CST 2024, time=2024-10-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2229828, encodeId=19f32229828de, content=审稿速度:6.0 偏重的研究方向：临床麻醉 经验分享：审稿特别特别慢，小修一次，之后又等了三个多月了，到现在啥消息也没有，据说是找不到审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec371560063, createdName=caoyanting2, createdTime=Tue Oct 08 15:44:11 CST 2024, time=2024-10-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192762, encodeId=88f62192e6261, content= 投稿需要 provide a separate document detailing the trial protocol in the English language only? 这个怎么写，感觉要写好多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9bb51305814, createdName=inchina888999, createdTime=Tue Mar 12 14:43:07 CST 2024, time=2024-03-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2214457, encodeId=c06e221445ecc, content=2024中的第二篇，给各位同志分享一下时间线以供参考 Submission received 30 Apr 2024 Submission is under technical check 30 Apr 2024 Amendment requested 14 May 2024 Amendment received 14 May 2024 Submission passed technical check 25 May 2024 Ready for editorial assignment 25 May 2024 Editor assigned 25 May 2024 Submission under peer review 28 May 2024 Revision requested 28 Jun 2024 Revision received 02 Jul 2024 Submission accepted 11 Jul 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Thu Jul 11 14:29:56 CST 2024, time=2024-07-11, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2211917, encodeId=2982221191ecc, content=投了一篇meta Submission received 07 Mar 2024 Submission passed technical check 07 Mar 2024 Editor assigned 13 Mar 2024 Submission under peer review 13 Mar 2024 Revision received 27 May 2024 Submission accepted 27 Jun 2024 Submission is in publishing and rights 27 Jun 2024 优点：英国老牌杂志，不算水刊，有一定认可度，编辑也比较友好，审稿人也比较负责，提的意见还算中肯，对meta友好。 缺点：BMC出了名的比较墨迹，编辑回邮件有的时候间隔时间很长。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Thu Jun 27 11:47:20 CST 2024, time=2024-06-27, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2204336, encodeId=9178220433690, content=审稿周期长，半年多才一审回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1455249596, createdName=147dadaam95暂无昵称, createdTime=Mon May 13 00:17:14 CST 2024, time=2024-05-13, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2183976, encodeId=856821839e6c6, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床研究 经验分享：投稿到接收不到4个月，挺顺利，一审小修，二审后直接接收！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96494708137, createdName=1468631587, createdTime=Thu Jan 25 22:03:29 CST 2024, time=2024-01-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2169625, encodeId=2ebc2169625d4, content=审稿速度:6.0 经验分享：现在审稿很墨迹，非常墨迹，得写几次催稿信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/p4eiaaeyWK5jaz5mPZiclWDxjXuM9aLBsbvyksLkRSTu03YPasOw7rxzqWvqVv5dPaZtV9pviatTnSIibmyXqMLzog/0, createdBy=2d701415129, createdName=bonnie-yh, createdTime=Mon Nov 20 08:54:20 CST 2023, time=2023-11-20, status=1, ipAttribution=广东省)]

2024-05-13 147dadaam95暂无昵称来自福建省

审稿周期长，半年多才一审回来。

0 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2280102, encodeId=256d228010205, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：临床麻醉学 经验分享： 两个半月接收三个月见刊在BMC系列里算快的了吧对创新性要求不强审稿不算太水也没太严格Submission received Submission status Date Submission received 03 Mar 2025 Technical check Submission status Date Submission is under technical check 03 Mar 2025 Amendment requested 04 Mar 2025 Amendment received 04 Mar 2025 Submission passed technical check 10 Mar 2025 Editorial assignment Submission status Date Ready for editorial assignment 10 Mar 2025 With editor Submission status Date Editor assigned 10 Mar 2025 Peer review Submission status Date First reviewer(s) invited 24 Apr 2025 Reviewer(s) accepted 24 Apr 2025 Reviewer report(s) received 24 Apr 2025 Revision requested 28 Apr 2025 Revision received 05 May 2025 Submission passed technical check 08 May 2025 First reviewer(s) invited 09 May 2025 Reviewer(s) accepted 10 May 2025 Reviewer report(s) received 10 May 2025 Revision requested 12 May 2025 Revision received 17 May 2025 Submission passed technical check 20 May 2025 Submission accepted Submission status Date Submission accepted 21 May 2025 Publishing and rights Submission status Date Submission is in publishing and rights 27 May 2025 Production Submission status Date Publishing and rights complete 29 May 2025, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210827/3f96cfbc51d94516954ad67041b7684d/191c72c642f24136aa1144f5d40df49e.jpg, createdBy=fab55511324, createdName=阿克赛普蒂德, createdTime=Fri Sep 05 11:16:19 CST 2025, time=2025-09-05, status=1, ipAttribution=京都府), GetPortalCommentsPageByObjectIdResponse(id=2217603, encodeId=958f221e6036a, content=2024年投的第三篇，前两篇基本都是三个月左右接受，第三篇龟速。4.22投，5.10开始外审，官网显示5.17收到审稿人报告，但是一直还是peer review的状态。给编辑发了好几封邮件均石沉大海。有点无语！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Tue Jul 30 15:22:38 CST 2024, time=2024-07-30, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2231274, encodeId=cfd522312e4cc, content=别投，3周还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b7a9138890, createdName=ms7000000580164983, createdTime=Thu Oct 17 06:20:12 CST 2024, time=2024-10-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2229828, encodeId=19f32229828de, content=审稿速度:6.0 偏重的研究方向：临床麻醉 经验分享：审稿特别特别慢，小修一次，之后又等了三个多月了，到现在啥消息也没有，据说是找不到审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec371560063, createdName=caoyanting2, createdTime=Tue Oct 08 15:44:11 CST 2024, time=2024-10-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192762, encodeId=88f62192e6261, content= 投稿需要 provide a separate document detailing the trial protocol in the English language only? 这个怎么写，感觉要写好多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9bb51305814, createdName=inchina888999, createdTime=Tue Mar 12 14:43:07 CST 2024, time=2024-03-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2214457, encodeId=c06e221445ecc, content=2024中的第二篇，给各位同志分享一下时间线以供参考 Submission received 30 Apr 2024 Submission is under technical check 30 Apr 2024 Amendment requested 14 May 2024 Amendment received 14 May 2024 Submission passed technical check 25 May 2024 Ready for editorial assignment 25 May 2024 Editor assigned 25 May 2024 Submission under peer review 28 May 2024 Revision requested 28 Jun 2024 Revision received 02 Jul 2024 Submission accepted 11 Jul 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Thu Jul 11 14:29:56 CST 2024, time=2024-07-11, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2211917, encodeId=2982221191ecc, content=投了一篇meta Submission received 07 Mar 2024 Submission passed technical check 07 Mar 2024 Editor assigned 13 Mar 2024 Submission under peer review 13 Mar 2024 Revision received 27 May 2024 Submission accepted 27 Jun 2024 Submission is in publishing and rights 27 Jun 2024 优点：英国老牌杂志，不算水刊，有一定认可度，编辑也比较友好，审稿人也比较负责，提的意见还算中肯，对meta友好。 缺点：BMC出了名的比较墨迹，编辑回邮件有的时候间隔时间很长。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Thu Jun 27 11:47:20 CST 2024, time=2024-06-27, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2204336, encodeId=9178220433690, content=审稿周期长，半年多才一审回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1455249596, createdName=147dadaam95暂无昵称, createdTime=Mon May 13 00:17:14 CST 2024, time=2024-05-13, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2183976, encodeId=856821839e6c6, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床研究 经验分享：投稿到接收不到4个月，挺顺利，一审小修，二审后直接接收！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96494708137, createdName=1468631587, createdTime=Thu Jan 25 22:03:29 CST 2024, time=2024-01-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2169625, encodeId=2ebc2169625d4, content=审稿速度:6.0 经验分享：现在审稿很墨迹，非常墨迹，得写几次催稿信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/p4eiaaeyWK5jaz5mPZiclWDxjXuM9aLBsbvyksLkRSTu03YPasOw7rxzqWvqVv5dPaZtV9pviatTnSIibmyXqMLzog/0, createdBy=2d701415129, createdName=bonnie-yh, createdTime=Mon Nov 20 08:54:20 CST 2023, time=2023-11-20, status=1, ipAttribution=广东省)]

2024-01-25 1468631587 来自四川省

审稿速度:3.0 | 投稿命中率:75.0
偏重的研究方向：临床研究
经验分享：投稿到接收不到4个月，挺顺利，一审小修，二审后直接接收！

170 3 举报

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2280102, encodeId=256d228010205, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：临床麻醉学 经验分享： 两个半月接收三个月见刊在BMC系列里算快的了吧对创新性要求不强审稿不算太水也没太严格Submission received Submission status Date Submission received 03 Mar 2025 Technical check Submission status Date Submission is under technical check 03 Mar 2025 Amendment requested 04 Mar 2025 Amendment received 04 Mar 2025 Submission passed technical check 10 Mar 2025 Editorial assignment Submission status Date Ready for editorial assignment 10 Mar 2025 With editor Submission status Date Editor assigned 10 Mar 2025 Peer review Submission status Date First reviewer(s) invited 24 Apr 2025 Reviewer(s) accepted 24 Apr 2025 Reviewer report(s) received 24 Apr 2025 Revision requested 28 Apr 2025 Revision received 05 May 2025 Submission passed technical check 08 May 2025 First reviewer(s) invited 09 May 2025 Reviewer(s) accepted 10 May 2025 Reviewer report(s) received 10 May 2025 Revision requested 12 May 2025 Revision received 17 May 2025 Submission passed technical check 20 May 2025 Submission accepted Submission status Date Submission accepted 21 May 2025 Publishing and rights Submission status Date Submission is in publishing and rights 27 May 2025 Production Submission status Date Publishing and rights complete 29 May 2025, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210827/3f96cfbc51d94516954ad67041b7684d/191c72c642f24136aa1144f5d40df49e.jpg, createdBy=fab55511324, createdName=阿克赛普蒂德, createdTime=Fri Sep 05 11:16:19 CST 2025, time=2025-09-05, status=1, ipAttribution=京都府), GetPortalCommentsPageByObjectIdResponse(id=2217603, encodeId=958f221e6036a, content=2024年投的第三篇，前两篇基本都是三个月左右接受，第三篇龟速。4.22投，5.10开始外审，官网显示5.17收到审稿人报告，但是一直还是peer review的状态。给编辑发了好几封邮件均石沉大海。有点无语！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Tue Jul 30 15:22:38 CST 2024, time=2024-07-30, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2231274, encodeId=cfd522312e4cc, content=别投，3周还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b7a9138890, createdName=ms7000000580164983, createdTime=Thu Oct 17 06:20:12 CST 2024, time=2024-10-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2229828, encodeId=19f32229828de, content=审稿速度:6.0 偏重的研究方向：临床麻醉 经验分享：审稿特别特别慢，小修一次，之后又等了三个多月了，到现在啥消息也没有，据说是找不到审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec371560063, createdName=caoyanting2, createdTime=Tue Oct 08 15:44:11 CST 2024, time=2024-10-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192762, encodeId=88f62192e6261, content= 投稿需要 provide a separate document detailing the trial protocol in the English language only? 这个怎么写，感觉要写好多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9bb51305814, createdName=inchina888999, createdTime=Tue Mar 12 14:43:07 CST 2024, time=2024-03-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2214457, encodeId=c06e221445ecc, content=2024中的第二篇，给各位同志分享一下时间线以供参考 Submission received 30 Apr 2024 Submission is under technical check 30 Apr 2024 Amendment requested 14 May 2024 Amendment received 14 May 2024 Submission passed technical check 25 May 2024 Ready for editorial assignment 25 May 2024 Editor assigned 25 May 2024 Submission under peer review 28 May 2024 Revision requested 28 Jun 2024 Revision received 02 Jul 2024 Submission accepted 11 Jul 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Thu Jul 11 14:29:56 CST 2024, time=2024-07-11, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2211917, encodeId=2982221191ecc, content=投了一篇meta Submission received 07 Mar 2024 Submission passed technical check 07 Mar 2024 Editor assigned 13 Mar 2024 Submission under peer review 13 Mar 2024 Revision received 27 May 2024 Submission accepted 27 Jun 2024 Submission is in publishing and rights 27 Jun 2024 优点：英国老牌杂志，不算水刊，有一定认可度，编辑也比较友好，审稿人也比较负责，提的意见还算中肯，对meta友好。 缺点：BMC出了名的比较墨迹，编辑回邮件有的时候间隔时间很长。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Thu Jun 27 11:47:20 CST 2024, time=2024-06-27, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2204336, encodeId=9178220433690, content=审稿周期长，半年多才一审回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1455249596, createdName=147dadaam95暂无昵称, createdTime=Mon May 13 00:17:14 CST 2024, time=2024-05-13, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2183976, encodeId=856821839e6c6, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床研究 经验分享：投稿到接收不到4个月，挺顺利，一审小修，二审后直接接收！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96494708137, createdName=1468631587, createdTime=Thu Jan 25 22:03:29 CST 2024, time=2024-01-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2169625, encodeId=2ebc2169625d4, content=审稿速度:6.0 经验分享：现在审稿很墨迹，非常墨迹，得写几次催稿信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/p4eiaaeyWK5jaz5mPZiclWDxjXuM9aLBsbvyksLkRSTu03YPasOw7rxzqWvqVv5dPaZtV9pviatTnSIibmyXqMLzog/0, createdBy=2d701415129, createdName=bonnie-yh, createdTime=Mon Nov 20 08:54:20 CST 2023, time=2023-11-20, status=1, ipAttribution=广东省)]

2023-11-20 bonnie-yh 来自广东省

审稿速度:6.0
经验分享：现在审稿很墨迹，非常墨迹，得写几次催稿信。

170 3 举报

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务